A Study of GC3107(BCG Vaccine) in Healthy Infants

Clinical trial NCT03947138 · COMPLETED

Trial details

NCT number: NCT03947138
Sponsor: Green Cross Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

BCG Vaccination Reaction Tuberculosis

Start date: 2019-08-06
Primary completion: 2022-06-20
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.